Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Stereotaxis

Stereotaxis reports first commercial robotic HD mapping cases with Magic catheter

By

Stereotaxis (NYSE:STXS) announced today that it completed the world's first commercial procedures using its Magic Sweep catheter. The MAGiC Sweep catheter is a high-density electrophysiology EP mapping catheter designed for use with Stereotaxis’ Robotic Magnetic Navigation systems. Dr. Raffaele Corbisiero and Dr. Pedram Kazemian performed the … [Read more...] about Stereotaxis reports first commercial robotic HD mapping cases with Magic catheter

Stereotaxis gets FDA green light for robotic electrophysiology mapping catheter

By

Stereotaxis (NYSE:STXS) announced today that it received FDA 510(k) clearance for its Magic Sweep navigation catheter. The company touts Magic Sweep as the world's first robotically navigated high-density electrophysiology (EP) mapping catheter. High-density mapping enhances cardiac ablation procedures through more efficient, detailed and precise … [Read more...] about Stereotaxis gets FDA green light for robotic electrophysiology mapping catheter

Stereotaxis shares data supporting Magic catheter

By

Stereotaxis (NYSE:STXS) announced the publication of initial clinical results using its MAGiC robotic magnetic navigation catheter. The results, published in the Journal of Interventional Cardiac Electrophysiology, mark the first peer-reviewed literature supporting the efficacy and safety of MAGiC. MAGiC, a robotically navigated magnetic ablation … [Read more...] about Stereotaxis shares data supporting Magic catheter

Stereotaxis submits pair of catheters for FDA clearance

By

Stereotaxis today announced it submitted its EMAGIN 5F and MAGiC catheters for FDA clearance. EMAGIN 5F, short for Endovascular Magnetic Intervention, is a 5-French diameter catheter that navigates tortuous venous and arterial vasculature. Stereotaxis designed it to enable efficient and safe navigation to access difficult-to-reach vascular … [Read more...] about Stereotaxis submits pair of catheters for FDA clearance

Stereotaxis Magic ablation catheter is now CE mark approved

By

Stereotaxis (NYSE:STXS) said today that it has secured CE mark approval for its Magic robotically-navigated magnetic ablation catheter. The St. Louis–based robotic surgery company submitted Magic for both CE mark and FDA approval nearly a year ago; it still awaits an FDA nod in the U.S. Magic performs cardiac ablation procedures to treat … [Read more...] about Stereotaxis Magic ablation catheter is now CE mark approved

Stereotaxis wins approval in China for magnetic ablation catheter

By

Stereotaxis (NYSE:STXS) announced today that its Magbot magnetic navigation ablation catheter received regulatory approval in China. This nod comes just weeks after the company won approval from China’s National Medical Products Administration for the Genesis robotic magnetic navigation (RNM) system. St. Louis, Missouri-based Stereotaxis aims to … [Read more...] about Stereotaxis wins approval in China for magnetic ablation catheter

Stereotaxis to acquire Access Point Technologies and its EP catheters

By

Stereotaxis (NYSE: STXS) is purchasing a Minneapolis-based electrophysiology (EP) catheter maker to further enhance its minimally invasive endovascular surgical robotics technology. St. Louis–based Stereotaxis did not disclose how much it is paying for Access Point Technologies in its after-hours news release. The transaction, paid with … [Read more...] about Stereotaxis to acquire Access Point Technologies and its EP catheters

The top catheter-based innovation news stories of 2024 — so far

By

Catheter innovations have had a remarkable year so far, with many receiving regulatory approval as they prepare to enter the market. The pulsed field ablation market heated up in 2023 and continues to make waves this year with more companies entering the space. Intravascular lithotripsy is having its moment as well – Shockwave Medical was … [Read more...] about The top catheter-based innovation news stories of 2024 — so far

Stereotaxis submits Magic ablation catheter for U.S., European approval

By

Stereotaxis (NYSE:STXS) announced that it submitted its Magic ablation catheter for both European and U.S. regulatory approval. The company said its FDA and CE mark submissions follow successful clinical results in an ongoing trial. Last month, Stereotaxis announced the first Magic treatments in the European trial supporting its submissions. … [Read more...] about Stereotaxis submits Magic ablation catheter for U.S., European approval

First patients treated using Stereotaxis MAGiC ablation catheter

By

Stereotaxis today announced the first patients have been successfully treated using its MAGiC magnetic interventional ablation catheter. The MAGiC catheter is a robotically navigated magnetic ablation catheter that performs minimally invasive cardiac ablation procedures. The first procedures were performed in Lithuania in eight patients … [Read more...] about First patients treated using Stereotaxis MAGiC ablation catheter